News

Pharmabiz2h
Bone Biologics seeks US patent for bone regeneration technology
Bone Biologics Corporation (Bone Biologics), a developer of orthobiologic products for spine fusion markets, announces the filing of a patent application with the United States Patent and Trademark ...
Pharmabiz11h
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...
Pharmabiz13h
Sobi’s Gamifant receives US FDA approval for first-ever treatment for adults and children with MAS in Still's disease
Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...
Pharmabiz15h
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drugs Consultative Commi ...
Pharmabiz12h
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints: Brussels, Belgium Monday, June 30, 2025, 11:00 Hrs [IST] UCB, a ...
Pharmabiz4h
BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US
BioPorto A/S, an in vitro diagnostics company, announced the initiation of commercialization in the US of ProNephro AKI (NGAL) for clinical use in risk stratification for moderate-to-severe AKI for ...
Pharmabiz12h
Torrent Pharma to acquire controlling stake in JB Chemicals & Pharmaceuticals
Torrent Pharmaceuticals has announced acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd from New York-based global investment firm KKR, with plans to merge the two entities ...
Pharmabiz5h
US FDA eliminates REMS for autologous chimeric antigen receptor CAR T cell immunotherapies
The US Food and Drug Administration (FDA) announced that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric ...
Pharmabiz14h
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar: Our Bureau, Mumbai Monday, June 30, 2025, 09:00 Hrs [IST] PharmatechnologyIndex.com Pvt Ltd is pl ...
Pharmabiz15h
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drug ...
Pharmabiz15h
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain: Shardul Nautiyal, Mumbai Monday, June 30, 2025, 08:00 Hrs [IST] The Pharmaceuti ...
Pharmabiz15h
DCGI responds on clarifications sought by Pharmexcil on export NOC guidance document
DCGI responds on clarifications sought by Pharmexcil on export NOC guidance document: Shardul Nautiyal, Mumbai Monday, June 30, 2025, 08:00 Hrs [IST] In order to ensure smooth imp ...